Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Methyl Propionate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103342718A reveals a novel route for 3-(methyl alkoxy phosphoryl) propionate. Achieve >95% yield without anhydrous conditions for cost-effective agrochemical manufacturing.
Advanced two-step transesterification process for high-purity beta-alkoxypropionamides. Reduces toxic solvent reliance and optimizes industrial manufacturing costs.
Patent CN105463033A reveals high-yield biocatalytic route for chiral intermediate. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN104313064A details a high-yield biocatalytic route for chiral esters. Discover cost-effective, scalable manufacturing for pharmaceutical intermediates.
Patent CN110963951A details a solvent-free, one-pot green synthesis for simvastatin side chains, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN109369447B reveals a novel ammonium salt acidification method for Meldonium, eliminating electrodialysis and ensuring high-purity pharmaceutical grade production.
Patent CN111747859A reveals a solvent-free synthesis route for N-(2,6-xylyl) methyl aminopropionate, offering high yields up to 97% and reduced environmental impact for fungicide manufacturing.
Patent CN108273523B reveals a low-pressure hydrogenation method for dabigatran intermediates using a novel Pt-Ni-WS2 catalyst, offering superior selectivity and solid product formation.
Patent CN108129303A reveals high-yield esterification for herbicide intermediates. Achieve superior purity and cost efficiency with scalable green chemistry solutions.
Patent CN104263768A reveals Candida biocatalysis for chiral esters. Offers high yield and ee. Reliable supply chain and cost reduction for pharmaceutical manufacturing.
Advanced solvent-free synthesis patent ensures high-purity antioxidant intermediates. Significant cost reduction and supply chain reliability for polymer additive manufacturing.
Patent CN114621986B reveals enzymatic synthesis for optically pure Taxol side chains. Discover cost-effective, scalable manufacturing solutions for pharmaceutical intermediates.
Patent CN116003384A reveals a novel synthetic route for dabigatran intermediates featuring early-stage cyclization and NHPI oxidation for superior yield and purity.
Patent CN105039436A details biocatalytic synthesis offering high yield and purity. This method ensures supply chain stability and cost efficiency for global pharmaceutical manufacturing partners.
Patent CN101585767B reveals a high-yield synthesis for 2-[4-(4-chlorobutyryl)phenyl]-2-methylpropionate, eliminating meta-isomers and reducing environmental impact for reliable supply.
Patent CN104328147A details a novel biocatalytic route for chiral esters offering high purity and scalable manufacturing solutions for global supply chains.
Patent CN103772223B details high-yield synthesis for pharmaceutical intermediates. Enhances supply chain reliability and cost efficiency significantly.
Patent CN104263769A details yeast-based reduction for high-purity chiral intermediates. Offers scalable, cost-effective manufacturing solutions for global supply chains.
Novel two-step synthesis reduces complexity for pharmaceutical intermediates. Enhances supply chain reliability and cost efficiency for global peptide manufacturing.
Patent CN115403465B reveals Pd-catalyzed CO2 utilization for esters. Offers green synthesis, reduced corrosion, and scalable supply chain solutions for fine chemical intermediates.